Association Between <i>KRAS</i> Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Lova Sun, Miles Hsu, Roger B. Cohen, Corey J. Langer, Ronac Mamtani, Charu Aggarwal
Abstract
Conflict of Interest Disclosures: Dr Odisho reported personal fees from VSee, LLC outside the submitted work. Dr Hong reported a
Topics & Concepts
MedicineKRASOncologyLung cancerInternal medicineCancerColorectal cancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations